BALTIMORE, Nov. 13, 2025 (GLOBE NEWSWIRE) -- The Urology Care Foundation (UCF), the official foundation of the American Urological Association (AUA), and the Prostate Cancer Foundation (PCF) today announced the launch of a new educational guide on genetic tests to guide treatment decisions for patients with advanced prostate cancer.

Prostate cancer is the most common cancer among men, and it's the second leading cause of cancer death for men in the U.S.

Prostate-specific antigen screening resulted in 13% lower prostate cancer mortality over a median 23 years of follow-up.

SCREENING men for prostate cancer could slash deaths by 13 per cent, saving thousands of lives a year, a study suggests. Results of the long-term European trial – one of the largest in

Investigators analyzed exfoliated cells in urine test specimens to identify 50 candidate RNAs for prostate cancer detection.

Fear of cancer, treatment side effects and misconceptions about masculinity may prevent men from prioritising their health, one doctor said.

Cal Hollman, 62, of Harrisburg, who survived being shot in the back in 1991, is encouraging men over 50 to get screened. 'It's been a hell of a journey.'